Af­ter years of fail­ures, the hunt for a new type of Parkin­son’s drug is on

Illustration by Kim Ryu for Endpoints News

When­ev­er re­search and de­vel­op­ment in­to new Parkin­son’s drugs are brought up, peo­ple tend to think of fail­ure — for good rea­son. There have been years up­on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.